儿童重症监护中疼痛、镇静、谵妄及医源性戒断管理临床实践指南与推荐的质量:系统评价方案
该文为系统评价方案,计划检索Medline ALL(Ovid)、Embase.com、CINAHL with Full Text(EBSCO)、JBI EBP Database(Ovid)等数据库、指南库及专业学会网站,纳入2010年至今发表、适用于新生儿至18岁儿童重症监护人群且包含至少一种上述情况评估推荐的临床实践指南。由两名独立评价者筛选、提取数据并使用AGREE II和AGREE Recommendation Excellence工具进行质量评价,结果以表格形式报告指南特征、内容与推荐。该方案已在PROSPERO注册(CRD42021274364),旨在为将指南推荐采纳至临床实践提供质量评价依据。
要点
- 系统评价方案计划评价儿童重症监护中疼痛、镇静、谵妄及医源性戒断管理指南的质量。
- 纳入标准:指南适用于新生儿至18岁儿童重症监护人群,且包含至少一种上述情况的评估推荐。
- 检索数据库包括Medline ALL(Ovid)、Embase.com、CINAHL with Full Text(EBSCO)、JBI EBP Database(Ovid),并检索指南库与专业学会网站。
- 纳入2010年至今发表的指南,由两名独立评价者使用AGREE II和AGREE Recommendation Excellence工具进行质量评价。
- 该方案已在PROSPERO注册,注册号CRD42021274364。
适用人群与场景
- 适用于儿童重症监护人群,年龄范围为新生儿至18岁。
- 纳入的指南需包含对疼痛、镇静、谵妄、医源性戒断中至少一种情况的评估推荐。
诊断标准与关键阈值
- 纳入标准:指南可应用于儿童重症监护人群(新生儿至18岁),且包含对疼痛、镇静、谵妄、医源性戒断中至少一种情况的评估推荐。
- 指南发表时间限定为2010年至今。
研究设计与关键结果
- 研究类型:系统评价方案。
- 检索数据库:Medline ALL(Ovid)、Embase.com、CINAHL with Full Text(EBSCO)、JBI EBP Database(Ovid),以及指南库和专业学会网站。
- 检索策略:将描述临床实践指南的索引词与自由词同疼痛、镇静、谵妄、戒断组合。
- 筛选与数据提取:由两名独立评价者进行 eligibility 筛选、数据提取和质量评价。
- 质量评价工具:AGREE II和AGREE Recommendation Excellence。
- 结果报告:以表格形式报告指南的特征、内容和推荐。
证据类型、等级与局限
- 证据类型:系统评价方案。
- 局限:原文未报告局限性。
指南或共识出处
- PROSPERO注册号:CRD42021274364。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Inadequate management of pain and sedation in critically ill children can cause unnecessary suffering and agitation, but also delirium and iatrogenic withdrawal. It is, therefore, important to address these four interrelated conditions together. Some clinical practice guidelines (CPGs) are available for the management of pain and sedation, and a few for delirium and iatrogenic withdrawal in the paediatric intensive care unit; none address the four conditions altogether. Critical appraisal of the quality of CPGs is necessary for their recommendations to be adopted into clinical practice. The aim of this systematic review is to identify and appraise the quality of CPGs and recommendations for management of either pain, sedation, delirium and iatrogenic withdrawal.
METHODS AND ANALYSIS: Researchers will conduct a systematic review in electronic databases (Medline ALL (Ovid), Embase.com, CINAHL with Full Text (EBSCO), JBI EBP Database (Ovid)), guideline repositories and websites of professional societies to identify CPGs published from 2010 to date. They will then combine index and free terms describing CPGs with pain, sedation, delirium and withdrawal. The researchers will include CPGs if they can be applied in the paediatric intensive care population (newborns to 18 years old) and include recommendation(s) for assessment of at least one of the four conditions. Two independent reviewers will screen for eligibility, complete data extraction and quality assessments using the Appraisal of Guidelines for Research and Evaluation (AGREE) II and the AGREE Recommendation Excellence instruments. Researchers will report characteristics, content and recommendations from CPGs in tabulated forms.
ETHICS AND DISSEMINATION: Ethical approval is not required for this systematic review. Results will be published in a peer-reviewed journal.
PROSPERO REGISTRATION NUMBER: CRD42021274364.
参考来源
- MacDonald I, Perez MH, Amiet V, et al. Quality of clinical practice guidelines and recommendations for the management of pain, sedation, delirium and iatrogenic withdrawal in pediatric intensive care: a systematic review protocol. BMJ Paediatr Open. 2022. PMID: 36053608. doi:10.1136/bmjpo-2021-001293
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。